Merck, Schering Wage PR Battle After Vytorin Backlash


CHARLOTTE, N.C. (AdAge.com) — Merck & Co. and Schering-Plough Corp., co-marketers of embattled cholesterol drug Vytorin, have gone into damage-control mode, taking out newspaper ads assuring the public that the drug they market is safe.

No Responses to “Merck, Schering Wage PR Battle After Vytorin Backlash”

Post a Comment